Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0CG1A
|
|||
Drug Name |
EBV-CTL
|
|||
Indication | Post-transplant lymphoproliferative disorder [ICD-11: 2B32; ICD-10: D47.Z1; ICD-9: 238.77] | Phase 2 | [1] | |
Company |
ATARA Biotherapeutics South San Francisco, CA
|
References | Top | |||
---|---|---|---|---|
REF 1 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.